Product Overview

Pantoprazole Sodium IP 40 mg [Gastro-Resistant] + Levosulpiride 75 mg [Sustained Release] is a combination pharmaceutical formulation developed for the management of acid-related gastrointestinal conditions associated with impaired gastric motility and digestive discomfort. The formulation combines effective gastric acid suppression with gastrointestinal prokinetic activity to provide comprehensive symptomatic support under medical supervision.

Pantoprazole Sodium belongs to the proton pump inhibitor (PPI) class and works by reducing excessive gastric acid production in the stomach. It inhibits the proton pumps responsible for the final stage of gastric acid secretion, helping relieve acidity, heartburn, and acid reflux while supporting the healing of acid-related irritation in the stomach and esophagus.

Levosulpiride is a prokinetic agent that helps improve gastrointestinal motility and supports the movement of food through the digestive tract. It may help relieve symptoms associated with delayed gastric emptying and impaired gastrointestinal movement, including bloating, early fullness, nausea, and upper abdominal discomfort.

The combination provides a dual-action approach by addressing both excessive acid production and gastrointestinal motility-related symptoms. The gastro-resistant form of Pantoprazole is designed to protect the active ingredient from degradation in the acidic environment of the stomach, while the sustained-release form of Levosulpiride is designed to provide prolonged therapeutic support.

Key Features

• Dual-action gastrointestinal formulation
• Helps reduce excessive gastric acid production
• Supports relief from acidity, heartburn, and acid reflux
• Promotes healthy gastrointestinal motility
• Helps manage bloating and digestive discomfort
• Gastro-resistant and sustained-release formulation
• Reliable and consistent therapeutic performance

Uses

• Gastroesophageal reflux disease (GERD) management
• Acidity and heartburn relief
• Acid reflux symptom management
• Functional dyspepsia support
• Delayed gastric emptying and impaired gastrointestinal motility
• Bloating, nausea, and upper abdominal discomfort associated with gastrointestinal disorders

How It Works

Pantoprazole Sodium reduces gastric acid secretion by inhibiting proton pumps in the stomach. Levosulpiride supports gastrointestinal motility and promotes coordinated movement of the digestive tract. Together, they help manage both acid-related symptoms and motility-associated digestive discomfort.

Possible Side Effects

Common side effects may include:

• Headache
• Nausea
• Abdominal discomfort
• Diarrhea or constipation
• Bloating
• Dizziness
• Fatigue

Patients should seek medical attention if severe allergic reactions, persistent abdominal pain, unusual movements, or other serious symptoms occur.

Precautions

• Use only under medical supervision
• Inform your doctor about liver, kidney, neurological, or hormonal conditions
• Inform your healthcare provider about all medications being taken
• Avoid prolonged self-medication
• Pregnant or breastfeeding women should consult a healthcare professional before use

Storage Instructions

Store in a cool, dry place away from direct sunlight, heat, and moisture. Keep out of reach of children and use before the expiry date mentioned on the packaging.

Quality Assurance

Manufactured under stringent pharmaceutical quality control procedures, the formulation undergoes comprehensive testing to ensure purity, safety, consistency, and dependable therapeutic performance. Each batch is carefully evaluated to maintain consistent pharmaceutical quality and reliable healthcare standards.